Teva

Ex-Teva exec to be new Hikma CEO

https://pharmaphorum.com/transversal-categories/uk-and-europe/ex-teva-exec-new-hikma-ceo/

Novartis/Amgen migraine drug reduces attacks after others fail

https://pharmaphorum.com/news/novartisamgen-migraine-drug-reduces-attacks-others-fail/

AZ’s cancer and respiratory drugs approved in Japan

https://pharmaphorum.com/news/azs-cancer-respiratory-drugs-approved-japan/

NHS funding for five MS drugs under threat

https://pharmaphorum.com/news/nhs-funding-five-ms-drugs-threat/

Teva’s huge cutbacks to slash workforce by 25%, close R&D sites

https://pharmaphorum.com/news/teva-slash-workforce-25-close-rd-sites/

GSK’s Nucala gains US use in rare autoimmune disease

https://pharmaphorum.com/news/gsks-nucala-gains-us-use-rare-autoimmune-disease/

Lilly chases Amgen with migraine drug filing

https://pharmaphorum.com/news/eli-lilly-files-migraine-drug-fda/

Novartis/Amgen’s migraine drug excites with phase 3 data

https://pharmaphorum.com/news/novartisamgen/

New Teva CEO axes R&D chief Hayden in boardroom shakeup

https://pharmaphorum.com/news/new-teva-ceo-axes-rd-chief-hayden-boardroom-shakeup/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com

Search